Prophylactic Human Vaccine Market Report

Europe Prophylactic Human Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 20, 2019
  • PAGES：185
  • REPORT CODE：GMM334625
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Prophylactic Human Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Prophylactic Human Vaccine Market Segmentations:

    By Player:

    • Merial

    • Shanghai BravoBio

    • Novavax Pasteur SA

    • GlaxoSmithKline

    • Pfizer

    • Janssen Pharmaceuticals

    • BiondVax Pharmaceuticals Ltd

    • Serum Institute of India Pvt

    • MedImmune

    • Bavarian Nordic A/S

    • Bharat Biotech International Limited

    • Hualan Biological Engineering

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prophylactic Human Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Prophylactic Human Vaccine Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Prophylactic Human Vaccine Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Prophylactic Human Vaccine Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Prophylactic Human Vaccine Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Prophylactic Human Vaccine Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Prophylactic Human Vaccine Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Prophylactic Human Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Prophylactic Human Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Prophylactic Human Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Prophylactic Human Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Prophylactic Human Vaccine for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Prophylactic Human Vaccine for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Prophylactic Human Vaccine for End-Users 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Prophylactic Human Vaccine Production Analysis by Top Regions

    • 5.2 Europe Prophylactic Human Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Prophylactic Human Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Prophylactic Human Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Prophylactic Human Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Prophylactic Human Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Prophylactic Human Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Prophylactic Human Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Prophylactic Human Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Prophylactic Human Vaccine Landscape Analysis

    • 7.1 Germany Prophylactic Human Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Prophylactic Human Vaccine Landscape Analysis by Major End-Users

    8. UK Prophylactic Human Vaccine Landscape Analysis

    • 8.1 UK Prophylactic Human Vaccine Landscape Analysis by Major Types

    • 8.2 UK Prophylactic Human Vaccine Landscape Analysis by Major End-Users

    9. France Prophylactic Human Vaccine Landscape Analysis

    • 9.1 France Prophylactic Human Vaccine Landscape Analysis by Major Types

    • 9.2 France Prophylactic Human Vaccine Landscape Analysis by Major End-Users

    10. Italy Prophylactic Human Vaccine Landscape Analysis

    • 10.1 Italy Prophylactic Human Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Prophylactic Human Vaccine Landscape Analysis by Major End-Users

    11. Spain Prophylactic Human Vaccine Landscape Analysis

    • 11.1 Spain Prophylactic Human Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Prophylactic Human Vaccine Landscape Analysis by Major End-Users

    12. Poland Prophylactic Human Vaccine Landscape Analysis

    • 12.1 Poland Prophylactic Human Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Prophylactic Human Vaccine Landscape Analysis by Major End-Users

    13. Russia Prophylactic Human Vaccine Landscape Analysis

    • 13.1 Russia Prophylactic Human Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Prophylactic Human Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Prophylactic Human Vaccine Landscape Analysis

    • 14.1 Switzerland Prophylactic Human Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Prophylactic Human Vaccine Landscape Analysis by Major End-Users

    15. Turkey Prophylactic Human Vaccine Landscape Analysis

    • 15.1 Turkey Prophylactic Human Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Prophylactic Human Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Prophylactic Human Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Prophylactic Human Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Prophylactic Human Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Prophylactic Human Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Prophylactic Human Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Prophylactic Human Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Prophylactic Human Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Prophylactic Human Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Prophylactic Human Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Prophylactic Human Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Prophylactic Human Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Merial

      • 19.1.1 Merial Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Shanghai BravoBio

      • 19.2.1 Shanghai BravoBio Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Novavax Pasteur SA

      • 19.3.1 Novavax Pasteur SA Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 GlaxoSmithKline

      • 19.4.1 GlaxoSmithKline Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Pfizer

      • 19.5.1 Pfizer Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Janssen Pharmaceuticals

      • 19.6.1 Janssen Pharmaceuticals Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 BiondVax Pharmaceuticals Ltd

      • 19.7.1 BiondVax Pharmaceuticals Ltd Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Serum Institute of India Pvt

      • 19.8.1 Serum Institute of India Pvt Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 MedImmune

      • 19.9.1 MedImmune Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Bavarian Nordic A/S

      • 19.10.1 Bavarian Nordic A/S Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Bharat Biotech International Limited

      • 19.11.1 Bharat Biotech International Limited Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Hualan Biological Engineering

      • 19.12.1 Hualan Biological Engineering Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    The List of Tables and Figures (Totals 96 Figures and 115 Tables)

    • Figure Product Picture

    • Figure Europe Prophylactic Human Vaccine Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Prophylactic Human Vaccine Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Prophylactic Human Vaccine Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Prophylactic Human Vaccine Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Prophylactic Human Vaccine Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Prophylactic Human Vaccine Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Prophylactic Human Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Prophylactic Human Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Prophylactic Human Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Prophylactic Human Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Prophylactic Human Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Prophylactic Human Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Prophylactic Human Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Prophylactic Human Vaccine Production by Major Regions

    • Table Europe Prophylactic Human Vaccine Production Share by Major Regions

    • Figure Europe Prophylactic Human Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Prophylactic Human Vaccine Consumption by Major Regions

    • Table Europe Prophylactic Human Vaccine Consumption Share by Major Regions

    • Table Germany Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    • Table France Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Prophylactic Human Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Prophylactic Human Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Prophylactic Human Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Prophylactic Human Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Prophylactic Human Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Prophylactic Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Prophylactic Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Prophylactic Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Prophylactic Human Vaccine Consumption by Types from 2014 to 2026

    • Table UK Prophylactic Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Prophylactic Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Prophylactic Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Prophylactic Human Vaccine Consumption by Types from 2014 to 2026

    • Table France Prophylactic Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Prophylactic Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Prophylactic Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Prophylactic Human Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Prophylactic Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Prophylactic Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Prophylactic Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Prophylactic Human Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Prophylactic Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Prophylactic Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Prophylactic Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Prophylactic Human Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Prophylactic Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Prophylactic Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Prophylactic Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Prophylactic Human Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Prophylactic Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Prophylactic Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Prophylactic Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Prophylactic Human Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Prophylactic Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Prophylactic Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Prophylactic Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Prophylactic Human Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Prophylactic Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Prophylactic Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Prophylactic Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prophylactic Human Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Prophylactic Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Prophylactic Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Prophylactic Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Prophylactic Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Prophylactic Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prophylactic Human Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Prophylactic Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Prophylactic Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Prophylactic Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prophylactic Human Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Prophylactic Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Prophylactic Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Prophylactic Human Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Merial

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merial

    • Figure Sales and Growth Rate Analysis of Merial

    • Figure Revenue and Market Share Analysis of Merial

    • Table Product and Service Introduction of Merial

    • Table Company Profile and Development Status of Shanghai BravoBio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai BravoBio

    • Figure Sales and Growth Rate Analysis of Shanghai BravoBio

    • Figure Revenue and Market Share Analysis of Shanghai BravoBio

    • Table Product and Service Introduction of Shanghai BravoBio

    • Table Company Profile and Development Status of Novavax Pasteur SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novavax Pasteur SA

    • Figure Sales and Growth Rate Analysis of Novavax Pasteur SA

    • Figure Revenue and Market Share Analysis of Novavax Pasteur SA

    • Table Product and Service Introduction of Novavax Pasteur SA

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Janssen Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals

    • Table Product and Service Introduction of Janssen Pharmaceuticals

    • Table Company Profile and Development Status of BiondVax Pharmaceuticals Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BiondVax Pharmaceuticals Ltd

    • Figure Sales and Growth Rate Analysis of BiondVax Pharmaceuticals Ltd

    • Figure Revenue and Market Share Analysis of BiondVax Pharmaceuticals Ltd

    • Table Product and Service Introduction of BiondVax Pharmaceuticals Ltd

    • Table Company Profile and Development Status of Serum Institute of India Pvt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India Pvt

    • Figure Sales and Growth Rate Analysis of Serum Institute of India Pvt

    • Figure Revenue and Market Share Analysis of Serum Institute of India Pvt

    • Table Product and Service Introduction of Serum Institute of India Pvt

    • Table Company Profile and Development Status of MedImmune

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedImmune

    • Figure Sales and Growth Rate Analysis of MedImmune

    • Figure Revenue and Market Share Analysis of MedImmune

    • Table Product and Service Introduction of MedImmune

    • Table Company Profile and Development Status of Bavarian Nordic A/S

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bavarian Nordic A/S

    • Figure Sales and Growth Rate Analysis of Bavarian Nordic A/S

    • Figure Revenue and Market Share Analysis of Bavarian Nordic A/S

    • Table Product and Service Introduction of Bavarian Nordic A/S

    • Table Company Profile and Development Status of Bharat Biotech International Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bharat Biotech International Limited

    • Figure Sales and Growth Rate Analysis of Bharat Biotech International Limited

    • Figure Revenue and Market Share Analysis of Bharat Biotech International Limited

    • Table Product and Service Introduction of Bharat Biotech International Limited

    • Table Company Profile and Development Status of Hualan Biological Engineering

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Biological Engineering

    • Figure Sales and Growth Rate Analysis of Hualan Biological Engineering

    • Figure Revenue and Market Share Analysis of Hualan Biological Engineering

    • Table Product and Service Introduction of Hualan Biological Engineering

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US